Skip to main content

Peripheral Neuropathy News

Related terms: Neuropathy

Risk Factors Do Not Explain Increased Peripheral Neuropathy Prevalence in Hispanics

TUESDAY, July 22, 2025 – Peripheral neuropathy (PN) risk factors seem to explain a higher prevalence of the disease among non-Hispanic Black individuals, but not among Hispanic individuals,...

Hispanic People Have Unexplained Higher Risk For Nerve Disorder

FRIDAY, July 18, 2025 — Hispanic people are more likely to develop peripheral neuropathy than white people, and it’s not clear why, a new study has found. Hispanic folks were 32% more likely than whi...

Four in 10 Patients Receiving Chemo Develop Chronic Painful Neuropathy

TUESDAY, Feb. 4, 2025 – The pooled prevalence of chronic painful neuropathy is 41.22 percent among individuals with chemotherapy-induced peripheral neuropathy (CIPN), according to a meta-analysis...

Chemo Causes Nerve Pain For Many Cancer Patients

WEDNESDAY, Jan. 29, 2025 – Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review suggests. These patients might experience loss of...

FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review

NEW YORK--(BUSINESS WIRE)--Jun 21, 2012 - Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the use of Lyrica (pregabalin) capsules CV for the management of...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

gabapentin, duloxetine, pregabalin